Density of tertiary lymphoid structures and their correlation with prognosis in non-small cell lung cancer

被引:0
|
作者
Xin, Shuyue [1 ]
Wen, Shuang [2 ]
He, Peipei [1 ]
Zhao, Yulong [1 ]
Zhao, Hui [1 ]
机构
[1] Dalian Med Univ, Dept Hlth Examinat Ctr, Affiliated Hosp 2, Dalian, Peoples R China
[2] Friendship Hosp Dalian, Dept Pathol, Dalian, Peoples R China
来源
FRONTIERS IN IMMUNOLOGY | 2024年 / 15卷
关键词
tertiary lymphoid structures (TLS); non-small cell lung cancer (NSCLC); prognosis; tumor immune microenvironment (TIME); nomogram; RELEVANCE; CD47;
D O I
10.3389/fimmu.2024.1423775
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background Tertiary lymphoid structures (TLS), ordered structure of tumor-infiltrating immune cells in tumor immune microenvironment (TIME), play an important role in the development and anti-tumor immunity of various cancers, including liver, colon, and gastric cancers. Previous studies have demonstrated that the presence of TLS in intra-tumoral (IT), invasive margin (IM), and peri-tumoral (PT) regions of the tumors at various maturity statuses. However, the density of TLS in different regions of non-small cell lung cancer (NSCLC) has not been extensively studied.Methods TLS and tumor-infiltrating immune cells were assessed using immunohistochemistry (IHC) staining in 82 NSCLC patients. Tumor samples were divided into three subregions as IT, IM and PT regions, and TLS were identified as early/primary TLS (E-TLS) or secondary/follicular TLS (F-TLS). The distribution of TLS in different maturity statuses, along with their correlation with clinicopathological characteristics and prognostic value, was assessed. Nomograms were used to predict the probability of 1-, 3-, and 5-year overall survival (OS) in patients with NSCLC.Results The density of TLS and proportion of F-TLS in the IT region (90.2%, 0.45/mm2, and 61.0%, respectively) were significantly higher than those in the IM region (72.0%, 0.18/mm2, and 39.0%, respectively) and PT region (67.1%, 0.16/mm2, and 40.2%, respectively). A lower density of TLS, especially E-TLS in the IM region, was correlated with better prognosis in NSCLC patients. CD20+ B cells, CD3+ T cells, CD8+ cytotoxic T cells, and CD68+ macrophages were significantly overexpressed in the IM region. CD20+ B cells and CD3+ T cells in the IM region were significantly correlated with the density of E-TLS, while no statistically significant correlation was found with F-TLS. The E-TLS density in the IM region and TNM stage were independent prognostic factors for NSCLC patients. The nomogram showed good prognostic ability.Conclusions A higher density of E-TLS in the IM region was associated with a worse prognosis in NSCLC patients, potentially due to the inhibition of TLS maturation caused by the increased density of suppressive immune cells at the tumor invasion front.
引用
收藏
页数:15
相关论文
共 50 条
  • [21] Correlation between respiratory function and prognosis of elderly patients with non-small cell lung cancer
    Chen, Jingjing
    Xiong, Junfang
    Zhao, Qingqing
    Cai, Xiaoping
    Chen, Guifen
    [J]. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2020, 127 : 316 - 316
  • [22] Correlation Analysis Among the Level of IL-35, Microvessel Density, Lymphatic Vessel Density, and Prognosis in Non-Small Cell Lung Cancer
    Zhang, Tenglong
    Nie, Jing
    Liu, Xiaojiang
    Han, Zenglei
    Ding, Ning
    Gai, Kai
    Liu, Yang
    Chen, Ling
    Guo, Chengye
    [J]. CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2021, 14 (01): : 389 - 394
  • [23] Tertiary lymphoid structures combined with biomarkers of inflammation are associated with the efficacy of neoadjuvant immunochemotherapy in resectable non-small cell lung cancer: A retrospective study
    Xu, Fuhao
    Zhu, He
    Xiong, Dali
    Wang, Kang
    Dong, Yinjun
    Li, Li
    Yuan, Shuanghu
    [J]. THORACIC CANCER, 2024, 15 (02) : 172 - 181
  • [24] Spatial tertiary lymphoid structures imply response to anti-PD-1 plus anlotinib in advanced non-small cell lung cancer
    Ma, Jianli
    Deng, Yuwei
    Zhang, Minghui
    Zhang, Qingyuan
    [J]. IMMUNOLOGY, 2024,
  • [25] Immunohistochemical typing of non-small cell lung cancer on cryostat sections:: correlation with clinical parameters and prognosis
    Hilbe, W
    Dirnhofer, S
    Oberwasserlechner, F
    Eisterer, W
    Ammann, K
    Schmid, T
    Hilbe, G
    Thaler, J
    Wöll, E
    [J]. JOURNAL OF CLINICAL PATHOLOGY, 2003, 56 (10) : 736 - 741
  • [26] Detection of serum SNHG22 and its correlation with prognosis of non-small cell lung cancer
    Cheng, Quan
    Chen, Guoping
    Wu, Xiaojiao
    Fang, Hang
    Shi, Jingjing
    Zhong, Bonian
    [J]. JOURNAL OF CARDIOTHORACIC SURGERY, 2024, 19 (01)
  • [27] Prognosis of Patients with Stage I Non-Small Cell Lung Cancer
    Flores, C. J.
    Chirinos, L.
    Enriquez, D.
    Schwarz, L. J.
    Mas, L.
    Rojas, V.
    Aguilar, A.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (11) : S1185 - S1185
  • [28] SMOX expression predicts the prognosis of non-small cell lung cancer
    Huang, Zhanghao
    Wang, Shuo
    Zhang, Hai-Jian
    Zhou, You Lang
    Shi, Jia-Hai
    [J]. ANNALS OF TRANSLATIONAL MEDICINE, 2021, 9 (13)
  • [29] Surgical treatment and prognosis of octogenarians with non-small cell lung cancer
    Zhang, Jing
    Xue, Zhi-Qiang
    Chu, Xiang-Yang
    Wang, Yun-Xi
    Zhao, Jia-Hua
    Xu, Chi
    Yin, Li-Guo
    [J]. ASIAN PACIFIC JOURNAL OF TROPICAL MEDICINE, 2012, 5 (06) : 465 - 468
  • [30] Research on correlation between tumor-stroma ratio and prognosis in non-small cell lung cancer
    Zhang, Xueqing
    Zhang, Yan
    Sun, Zongwen
    Ma, Huiping
    [J]. MINERVA MEDICA, 2019, 110 (06) : 590 - 592